HAFN in Stage 2 Uptrend, 2-Week Consolidation near 11.06 Pivot

HAFN stock profile infographic with daily candles, 20, 50 and 150-day simple moving averages and volume, Stage 2 (Advancing), as of November 13, 2026 at 00:02 — CANSLIM Research
HAFN is holding a Stage 2 advancing structure above a rising 30-week moving average, with price 109% above its 52-week low and 14.3% off its high. The market is focused on a short two-week consolidation with a pivot at 11.06, which is not yet a fully formed base and shows no VCP contraction or volume dry-up. Sentiment is constructive but unconfirmed, with a bear flag and price below the 50-day MA arguing for patience until a breakout or further tightening.

HAFN   Daily · data to 2026-11-12 close · 20 SMA 50 SMA 150 SMA
Frozen at publication – this chart does not move. Open live chart on TradingView →

SECTORIndustrialsINDUSTRYMarine ShippingStage 2Weinstein stage
Intraday data, US market still open (as of Thu 12 Nov 11:02 ET)Created: Fri 13 Nov 00:02 HKT = 11:02 ET

Inside the Full Report

  • 🔒
    Stage AnalysisWhy the stock sits in this stage and what would change that
  • 🔒
    Detected PatternsWhich setups the scan found, with buy point and failure level
  • 🔒
    Trend Template: All 8 ChecksWhich criteria pass, which fail, and by how much
  • 🔒
    Fundamental SnapshotGrowth, margins, valuation and the earnings date


Disclaimer: This report is for informational and educational purposes only and does not constitute investment advice. Figures come from the scanned result (as of November 13, 2026) and company filings; all estimates not explicitly sourced from the provided data are clearly labeled as such. The analysis may contain errors — always verify against primary filings (10-K/10-Q/8-K) before making any investment decision.

About CANSLIM Research

CANSLIM Research is an independent project using AI to analyze global financial data by applying rule-based algorithms derived from well-known momentum traders. Our AI personas—simulations inspired by these methods with no trader affiliation or endorsement—scan stocks, analyze charts, track sector rotation, and publish educational insights under human oversight. Support via contributions, sponsorship, or partnership never buys stock-specific access, influences publishing, or involves paid security features. We are not a registered charity.

Disclaimer: All content is strictly educational—not investment advice, recommendations, or buy/sell solicitations. CANSLIM Research is not a licensed adviser or analyst under any regulatory body (including SEC, FINRA, SFC, FCA, SEBI, or EU authorities under ESMA). Investing carries risk of total loss, and past performance does not predict future results. Consult a licensed financial adviser before investing.